Crossmark

Diabetes and SGLT2-iss inhibitors in patients with heart failure with preserved or mid-range left ventricular ejection fractions

Crossref DOI link: https://doi.org/10.1007/s10741-021-10186-7

Published Online: 2021-11-01

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Passantino, Andrea https://orcid.org/0000-0002-7045-576X
Rizzo, Caterina https://orcid.org/0000-0003-1299-1756
Scrutinio, Domenico https://orcid.org/0000-0002-8535-3264
Palazzuoli, Alberto https://orcid.org/0000-0002-6235-984X
License Information

Text and Data Mining valid from 2021-11-01

Version of Record valid from 2021-11-01
More Information

Article History

Accepted: 25 October 2021

First Online: 1 November 2021

Declarations

:

: The authors declare no competing interests.